# Treatment of Pneumocystis in COPD (the TOPIC Study)

> **NCT05418777** · PHASE1,PHASE2 · TERMINATED · sponsor: **Corewell Health East** · enrollment: 1 (actual)

## Conditions studied

- COPD Exacerbation Acute

## Interventions

- **DRUG:** Trimethoprim Sulfamethoxazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05418777
- **Lead sponsor:** Corewell Health East
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-09-28
- **Primary completion:** 2022-12-19
- **Final completion:** 2022-12-19
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** lack of enrollment
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05418777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05418777, "Treatment of Pneumocystis in COPD (the TOPIC Study)". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT05418777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*